Catalyst Wire Dossier Catalyst Wire Dossier

SNP-ACTH (1-39) Gel

ACTH (1-39) gel · Cerium Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SNP-ACTH (1-39) Gel, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy [Phase 3]

See pricing